- Use anti-TNF-alfa blockade effect in treatment of rheumatoid arthritis2001 | First Faculty of Medicine
- Promt and long-term effect of golimumab in the treatment of advanced ankylosing spondylitis2012 | Faculty of Medicine in Hradec Králové
- Adalimumab in a Clinical Practice - Experience with Human Anti TNF-alpha Therapy in Tertiary Clinical CenterPublication without faculty affiliation
- Psoriasis - overwiew of the disease and indications for the biological treatment. Our experiences with adalimumab treatment2020 | Faculty of Medicine in Hradec Králové
- Register of anti-TNF alfa therapy in Czech RepublicPublication without faculty affiliation
- Anti - TNF-alfa antibody infliximab in the treatment of Wegener´s granulomatosisPublication without faculty affiliation
- Safety of therapy with TNF blocking agents by rheumatic patiens with hepatitis B and C2007 | First Faculty of Medicine
- Current Approach to Modern Treatment of Psoriasis - Updated Guidelines of ČDS JEP for Targeted Treatment of Severe Chronic Psoriasis2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- A Randomized, Double-Blind, Placebo-Controlled Trial of the Human Anti-TNF-alfa Monoclonal Antibody Adalimumab for the Induction of Remission in Patients with Moderate to Severely Active Crohn´s DiseasePublication without faculty affiliation
- Infliximab as a treatment of inflammatory bowel disease2012 | First Faculty of Medicine
- Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 20132016 | Faculty of Medicine in Pilsen
- Long-term therapy of idiopathic inflammatory bowel disease2012 | First Faculty of Medicine
- Immunopathological complications of anti-TNF-alpha biological treatment2016 | First Faculty of Medicine
- Biological therapy of Crohn's disease2012 | First Faculty of Medicine
- Issue of tuberculosis associated with TNF blocking treatment in the Czech Republic2006 | First Faculty of Medicine
- The Influence of Long Term Therapy with Adalimumab on Biomarkers of Systemic Inflammation in Psoriasis2021 | Third Faculty of Medicine
- The effect of treatment of rheumatic diseases on cardiovascular risk2018 | First Faculty of Medicine
- Gastrointestinal toxicity of systemic oncology immunotherapy2022 | First Faculty of Medicine, Central Library of Charles University